Showing results (291-300 of 335) with videos related to

Sort By:
Pageof 34
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2010
Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognitionSandra M Mueller, Bernd M Spriewald, Silke Bergmann, et al.
Open Forum Infectious Diseases|September 23, 2020
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS StudyChristoph D Spinner, Tim Kümmerle, Jochen Schneider, et al.
Food & Nutrition Research|February 13, 2013
ILSI Brazil International Workshop on Functional Foods: a narrative review of the scientific evidence in the area of carbohydrates, microbiome, and healthMarie E Latulippe, Agnès Meheust, Livia Augustin, et al.
Scientific Reports|December 8, 2017
A Pilot Characterization of the Human ChronobiomeCarsten Skarke, Nicholas F Lahens, Seth D Rhoades, et al.
AIDS (London, England)|July 20, 2002
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)Hans-Jürgen Stellbrink, Jan van Lunzen, Michael Westby, et al.
Cytokine|February 22, 2021
The concomitant use of cannabis and cocaine coexists with increased LPS levels and systemic inflammation in male drug usersCamila Bastos Ribeiro, Fernanda de Oliveira Feitosa de Castro, Gilson Pires Dorneles, et al.
Antiviral Therapy|July 30, 2019
Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trialJose M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2008
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patientsChristoph Wyen, Heidy Hendra, Martin Vogel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2025
[18F]FDG-PET/CT-based evaluation of tumor response kinetics during induction chemotherapy and concurrent radiochemotherapy in stage II - III small-cell lung cancerChristian Hoffmann, Hubertus Hautzel, Marcel Wiesweg, et al.
AIDS (London, England)|October 17, 2022
Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIVErich S Tusch, Lene Ryom, Olga Fursa, et al.
Pageof 34